3rd Circ. Wipes Out FTC's $448M AbbVie Win
The Third Circuit on Wednesday reversed a court-ordered $448 million penalty against AbbVie and Besins for allegedly delaying generic forms of the testosterone treatment AndroGel through sham litigation, pointing to the...To view the full article, register now.
Already a subscriber? Click here to view full article